DOCTORAL NETWORK
PLASMA MEDICINE AGAINST
ACTINIC KERATOSIS
in germany
developed an actinic keratosis by age 60
About PlasmACT
What is PlasmACT?
PlasmACT is a Marie Skłodowska-Curie Doctoral Network coordinated by the Leibniz Institute for Plasma Research and Technology in Greifswald, Germany, in collaboration with four other academic partners:
University Medical Center Rostock, Germany,
Eindhoven University of Technology, The Netherlands,
Centre national de la recherche scientifique, France and
University of Antwerp, Belgium.
In addition to our partners, our project also includes eight associated industry partners and two NGOs.
Our mission is to explore the potential of medical gas plasma technology in treating Actinic Keratosis, a common skin condition that can lead to skin cancer.
Latest News
Here you will find our latest news about our doctoral network PlasmACT.
January 14, 2026
Stripe Young Scientist & Technology Exhibition
Last week, the PlasmACT team had the incredible opportunity to represent the Marie Skłodowska-Curie Actions (MSCA), the European Commission, and the ScienceisWonderful! initiative at the Stripe Young Scientist & Technology Exhibition, along with colleagues from the European Parliament Liaison Office in Ireland, in Dublin – EU Science, Research and Innovation
December 7, 2025
Publication Alert
We are delighted to share that Zengyu W. (DC1) has published a new review article titled “Biomolecular Mass Spectrometry in Plasma Medicine.” This marks the second scientific publication from the PlasmACT Doctoral Network, showcasing the breadth and depth of research emerging from our consortium.
June 17, 2025
Training School on Plasma Cancer Treatment
We’re thrilled to share that our PlasmACT Training Day, co-located with PlasTHER COST Action in Barcelona, was a great success!
The day was filled with inspiring talks and engaging discussions on the potential of gas plasma in cancer research and therapy. It was energizing to see such a passionate and collaborative community coming together to explore this exciting field.







